home *** CD-ROM | disk | FTP | other *** search
- SRC.c01.A.1,see Kidney cancer,c17.A.6
- SRC.c01.A.6,SEE "THYROID",C42.A.1
- SRC.c01.C.1,see Kidney cancer,c17.C.6
- SRC.c01.C.6,SEE "THYROID",C42.C.1
- SRC.c02.A.17,see Laser Therapy,p09.a.1
- SRC.c03.A.1,see diagram in Gall Bladder Cancer,c13.a.8
- SRC.C03.C.1,see diagram in Gall Bladder Cancer,c13.c.8
- SRC.c06.A.13,see BIOPSY DIAGRAM,p02.a.24
- SRC.c06.A.23,RADIATION THERAPY,p06.A.16
- SRC.c06.A.23,TREATMENT SIDE EFFECTS,p17.A.1
- SRC.c06.A.28,see BONE MARROW TRANSPLANTATION,P12.a.10
- SRC.c06.A.28,see BIOLOGICAL THERAPY,P08.A.17
- SRC.c06.A.36,see "STAGE II",c06.a.34
- SRC.c06.A.48,"STAGE IIIA",C06.A.39
- SRC.c06.A.48,"STAGE IV",C06.A.41
- SRC.c06.A.48,see INVESTIGATIONAL ANTICANCER DRUGS,P35.A.1
- SRC.c06.C.13,see BIOPSY DIAGRAM,p02.C.24
- SRC.c06.C.24,RADIATION THERAPY,p06.C.16
- SRC.c06.C.24,TREATMENT SIDE EFFECTS,p17.C.1
- SRC.c06.C.28,see BONE MARROW TRANSPLANTATION,P12.C.10
- SRC.c06.C.29,see BIOLOGICAL THERAPY,P08.C.17
- SRC.c06.C.38,SEE "STAGE II",C06.c.36
- SRC.c06.C.51,"STAGE IIIA",C06.C.42
- SRC.c06.C.51,"STAGE IV",C06.A.44
- SRC.c06.C.51,see INVESTIGATIONAL ANTICANCER DRUGS,P35.C.1
- SRC.c07.A.3,see also "SPECIAL PATHOLOGIC METHODS",C07.A.7
- SRC.c07.C.4,see also "SPECIAL PATHOLOGIC METHODS",C07.C.8
- SRC.c08.A.13,see "RECURRENT CANCER",C08.A.15
- SRC.c08.C.14,see "RECURRENT CANCER",C08.C.16
- SRC.c08.C.2,SEE "COMMON SIGNS AND SYMPTOMS",C08.C.5
- SRC.c08.A.2,see"Common Signs and Symptoms",C08.A.5
- SRC.c10a.A.15,see BONE MARROW TRANSPLANTATION,P12.A.24
- SRC.c10a.A.3,SEE "RISK FACTORS",C10A.A.5
- SRC.c10a.C.15,see BONE MARROW TRANSPLANTATION,P12.C.23
- SRC.c10a.C.3,SEE "RISK FACTORS",C10A.C.5
- SRC.c11b.A.1,see Living with an Ostomy,P21.A.1
- SRC.c11b.A.13,See also STAGE II.,C11B.A.7
- SRC.c11b.A.15,see WHAT HAPPENS IN SURGERY,P05.A.1
- SRC.c11b.A.19,see "Metastatic Cancer",C27.A.12
- SRC.c11b.A.21,See Summary of Consensus Conference on Colon and Rectal Cancer,C11C.A.16
- SRC.c11b.A.21,See Investigational Anticancer Drugs,P35.A.13
- SRC.c11b.A.3,see LASER THERAPY,P09.A.7
- SRC.c11b.C.1,see UNDERSTANDING AN OSTOMY,P21.C.1
- SRC.c11b.C.13,See also STAGE II.,C11B.C.7
- SRC.c11b.C.15,see WHAT HAPPENS IN SURGERY,P05.C.1
- SRC.c11b.C.16,see "METASTATIC CANCER",C27.C.11
- SRC.c11b.C.19,see "METASTATIC CANCER",C27.C.12
- SRC.c11b.C.21,See Summary of Consensus Conference on Colon and Rectal Cancer,C11C.C.17
- SRC.c11b.c.21,See Investigational Anticancer Drugs,P35.C.9
- SRC.c11b.C.3,see LASER THERAPY,P09.C.7
- SRC.c11c.A.11,See Summary of Consensus Conference on Colon and Rectal Cancer,C11C.A.16
- SRC.c11c.A.13,SEE "STAGE IV",C11C.A.10
- SRC.c11c.A.2,see OSTOMY,P21.a.1
- SRC.c11c.A.4,see LASER THERAPY,P09.A.7
- SRC.c11c.A.5,See Stage 1 Colon Cancer Diagram,C11B.A.6
- SRC.c11c.A.6,See STAGE II COLON DIAGRAM,C11B.A.7
- SRC.c11c.A.8,See STAGE III COLON DIAGRAM,C11B.a.10
- SRC.c11c.C.12,See Summary of Consensus Conference on Colon and Rectal Cancer,C11C.C.17
- SRC.c11c.C.14,SEE "STAGE IV",C11C.C.11
- SRC.c11c.C.2,see OSTOMY,P21.C.1
- SRC.c11c.C.4,see LASER THERAPY,P09.C.7
- SRC.c31.A.12,See Maintaining Good Nutritrion,P18.A.1
- SRC.c31.A.15,see Stage 1,c31.A.13
- SRC.c31.A.17,see STAGES II,c31.A.14
- SRC.c31.A.17,III,c31.A.16
- SRC.c31.A.2,See Diagram,c13.a.8
- SRC.c31.C.12,See Maintaining Good Nutritrion,P18.C.1
- SRC.c31.C.15,see "Palliation" section,c31.C.11
- SRC.c31.C.17,see Stages II,c31.A.14
- SRC.c31.C.17,III,c31.A.16
- SRC.c31.C.2,See Diagram,c13.a.8
- SRC.c31.C.2,see "ISLET CELL AND OTHER PANCREATIC CARCINOMAS",c15.c.1
- SRC.c32.A.1,see Figure,c42.A.6
- SRC.c32.C.1,see "Thyroid",c42.C.6
- SRC.c34.A.1,see Areas in the brain,c05.A.5
- SRC.c34.C.1,see Areas in the brain,c05.C.6
- SRC.c36.A.14,see "Childhood Cancer: Soft Tissue And Bone Sarcomas",c10d.A.1
- SRC.c36.C.14,see "Childhood Cancer: Soft Tissue And Bone Sarcomas",c10d.C.1
- SRC.c36.A.1,CHILDHOOD CANCERS: SOFT TISSUE AND BONE SARCOMAS,c10d.A.1
- SRC.c36.A.1,KAPOSI'S SARCOMA,c16.A.1
- SRC.c36.A.1,MESOTHELIOMA,c26.A.1
- SRC.c36.A.1,UTERUS: UTERINE SARCOMAS,c45.A.1
- SRC.c36.C.1,CHILDHOOD CANCERS: SOFT TISSUE AND BONE SARCOMAS,c10d.C.1
- SRC.c36.C.1,KAPOSI'S SARCOMA,c16.C.1
- SRC.c36.C.1,MESOTHELIOMA,c26.C.1
- SRC.c36.C.1,UTERUS: UTERINE SARCOMAS,c45.C.1
- SRC.c37.A.1,see also "Melanoma",c25.A.1
- SRC.c37.C.1,see also "Melanoma",c25.C.1
- SRC.c38.A.13,See "CARCINOIDS OF THE GASTROINTESTINAL TRACT",c08.A.1
- SRC.c38.A.13,see "LYMPHOMAS: NON-HODGKIN'S",c24.A.1
- SRC.c38.A.15,see "MAINTAINING GOOD NUTRITION",p18.A.1
- SRC.c38.A.2,see "CARCINOIDS OF THE GASTROINTESTINAL TRACT",c08.A.1
- SRC.c38.C.13,See "CARCINOIDS OF THE GASTROINTESTINAL TRACT",c08.C.1
- SRC.c38.C.13,see "LYMPHOMAS: NON-HODGKIN'S",c24.C.1
- SRC.c38.C.15,see "MAINTAINING GOOD NUTRITION",p18.C.1
- SRC.c38.C.2,see "CARCINOIDS OF THE GASTROINTESTINAL TRACT",c08.C.1
- SRC.c39.A.22,see "LASER THERAPY",p09.A.1
- SRC.c39.C.21,see "LASER THERAPY",p09.C.1
- SRC.c42.A.2,"Adrenal Gland",c01.A.1
- SRC.c42.A.2,"PARATHYROID",c32.A.1
- SRC.c42.A.2,"ISLET CELL AND OTHER PANCREATIC CARCINOMAS",c15.A.1
- SRC.c42.A.23,see "LYMPHOMAS: NON-HODGKIN'S",c24.A.1
- SRC.c42.C.2,"Adrenal Gland",c01.C.1
- SRC.c42.C.2,"PARATHYROID",c32.C.1
- SRC.c42.C.2,"ISLET CELL AND OTHER PANCREATIC CARCINOMAS",c15.C.1
- SRC.c42.C.24,see "LYMPHOMAS: NON-HODGKIN'S",c24.C.1
- SRC.c44.A.2,See "UTERUS: UTERINE SARCOMAS".,c45.A.1
- SRC.c44.A.2,see Cancers of female pelvic organs,c09.A.4
- SRC.c44.A.2,See OVARIAN GERM CELL TUMORS.",c30.A.1
- SRC.c44.A.7,see Endometrial Cancer Precursors,c44.A.9
- SRC.c44.C.2,See "UTERUS: UTERINE SARCOMAS.",c45.C.1
- SRC.c44.C.2,see Cancers of female pelvic organs,c09.C.4
- SRC.c44.C.2,See "OVARY.",c29.C.1
- SRC.c45.A.1,see "UTERUS: ENDOMETRIAL CARCINOMA",c44.A.1
- SRC.c45.A.1,see "CANCERS OF FEMALE PELVIC ORGANS",c09.A.4
- SRC.c45.A.2,see "CANCERS OF FEMALE PELVIC ORGANS",c09.A.4
- SRC.c45.C.1,see "UTERUS: ENDOMETRIAL CARCINOMA",c44.C.1
- SRC.c45.C.1,see "CERVIX",c09.C.1
- SRC.c45.C.2,see "CANCERS OF FEMALE PELVIC ORGANS",c09.C.4
- SRC.C45.A.5, See "Uterus: Endometrial Carcinoma",c44.A.1
- SRC.C45.A.6, See "Uterus: Endometrial Carcinoma",c44.A.1
- SRC.C45.A.7, See "Uterus: Endometrial Carcinoma",c44.A.1
- SRC.C45.A.8, See "Uterus: Endometrial Carcinoma",c44.A.1
- SRC.C45.A.9, See "Uterus: Endometrial Carcinoma",c44.A.1
- SRC.C45.A.15,See "Endometrial Carcinoma",c44.A.1
- SRC.C45.A.18,See "Endometrial Carcinoma",c44.A.1
- SRC.C45.C.5,See "Uterus: Endometrial Carcinoma",c44.C.1
- SRC.C45.C.6,See "Uterus: Endometrial Carcinoma",c44.C.1
- SRC.C45.C.7,See "Uterus: Endometrial Carcinoma",c44.C.1
- SRC.C45.C.8,See "Uterus: Endometrial Carcinoma",c44.C.1
- SRC.C45.C.9,See "Uterus: Endometrial Carcinoma",c44.C.1
- SRC.C45.C.15,See "Endometrial Carcinoma",c44.C.1
- SRC.C45.C.18,See "Endometrial Carcinoma",c44.C.1
- SRC.c46.A.14,see "MELANOMA",c25.A.1
- SRC.c46.A.2,See "CANCERS OF FEMALE PELVIC ORGANS",c09.A.4
- SRC.c46.C.13,see "MELANOMA",c25.C.1
- SRC.c46.C.2,See "CANCERS OF FEMALE PELVIC ORGANS",C09.C.4
- SRC.c47.A.2,See "CANCERS OF FEMALE PELVIC ORGANS",C09.A.4
- SRC.c47.C.2,See "CANCERS OF FEMALE PELVIC ORGANS",c09.C.4
- SRC.P01.A.9,SEE INVESTIGATIONAL ANTICANCER DRUGS,P34.A.1
- SRC.P01.C.9,SEE INVESTIGATIONAL ANTICANCER DRUGS,P34.C.1
- SRC.p01.A.18,see TABLE: Staging For Breast Carcinoma,P01.A.19
- SRC.p01.C.18,see TABLE: Staging For Breast Carcinoma,P01.C.19
- SRC.p02.A.17,see "LASER THERAPY",p09.A.1
- SRC.p02.C.18,see "LASER THERAPY",p09.C.1
- SRC.p02.A.22,see Figure: TYPES OF BIOPSY FOR CANCER DIAGNOSIS,p02.A.24
- SRC.p02.A.6,see Bronchoscope,p02.A.22
- SRC.p02.C.17,see "LASER THERAPY",p09.C.1
- SRC.p02.C.22,see Figure: TYPES OF BIOPSY FOR CANCER DIAGNOSIS,p02.C.24
- SRC.p02.C.6,see Bronchoscope,p02.C.22
- SRC.p03.A.17,see "SURVIVORSHIP",p31.A.1
- SRC.p03.C.18,see "SURVIVORSHIP",p31.C.1
- SRC.p03.A.5,see "THE ONCOLOGY NURSE",p15.A.1
- SRC.p03.C.5,see "THE ONCOLOGY NURSE",p15.C.1
- SRC.p04.A.11,see "ACCESS TO CANCER INFORMATION",p37.A.1
- SRC.p04.C.11,see "ACCESS TO CANCER INFORMATION",p37.C.1
- SRC.c11c.C.5,See Stage 1 Colon Cancer Diagram,c11b.c.6
- SRC.c11c.C.6,see Stage II colon diagram,c11b.c.7
- SRC.c11c.C.9,see Stage III colon diagram,c11b.c.10
- SRC.c12.A.14,see "STOMACH",c39.a.1
- SRC.c12.A.15,see Laser Therapy,p09.a.1
- SRC.c12.A.20,see Laser Therapy,p09.a.1
- SRC.c12.C.14,see "STOMACH",c39.c.1
- SRC.c12.C.15,see Laser Therapy,p09.c.1
- SRC.c12.C.20,see Laser Therapy,p09.c.1
- SRC.c14a.A.3,see also "CANCER OF AN UNKNOWN PRIMARY SITE",c07.a.1
- SRC.c14a.C.2,see also "CANCER OF AN UNKNOWN PRIMARY SITE",c07.a.1
- SRC.c15.A.1,see Diagram in Gall Bladder Cancer,c13.A.8
- SRC.c15.C.1,see Diagram in Gall Bladder Cancer,c13.C.8
- SRC.c16.A.22,see The Look Good...Feel Better Cosmetic Program,p22.A.1
- SRC.c16.C.22,see The Look Good...Feel Better Cosmetic Program,p22.C.1
- SRC.c17.A.2,See "CHILDHOOD CANCERS",c10a.a.1
- SRC.c17.C.2,See "CHILDHOOD CANCERS",c10a.c.1
- SRC.c18.A.10,see Bone Marrow Transplantation,p12.a.1
- SRC.c18.C.10,see Bone Marrow Transplantation,p12.c.1
- SRC.c19.A.1,see "BILE DUCT",c03.a.1
- SRC.c19.A.2,see "METASTATIC CANCER",c27.a.1
- SRC.c19.A.2,see Diagram in Gall Bladder Cancer,c13.a.8
- SRC.c19.C.2,see "BILE DUCT",c03.c.1
- SRC.c19.C.2,see "METASTATIC CANCER",c27.c.1
- SRC.c20.C.23,See Treatment for Stage IV disease,c20.C.18
- SRC.c20.A.23,See treatment for Stage IV disease,c20.A.18
- SRC.c20.A.11,see Laser Therapy,p09.a.1
- SRC.c20.A.20,see Coping with Treatment Side Effects,p17.a.1
- SRC.c20.C.11,see Laser Therapy,p09.c.1
- SRC.c20.C.20,see Coping with Treatment Side Effects,p17.c.1
- SRC.c23.A.14,see Biological Therapy,p08.a.1
- SRC.c23.C.14,see Biological Therapy,p08.c.1
- SRC.c24.A.23,See also "Lymphoma: AIDS-Associated",c22.a.1
- SRC.c24.A.19,Treatment Overview by Grade,c24.a.12
- SRC.c24.C.22,See also "Lymphoma: AIDS-Associated",c22.c.1
- SRC.c25.A.15,See also Hyperthermic Perfusion Therapy,p11.a.1
- SRC.c25.A.18,see Biological Therapy,p08.a.1
- SRC.c25.A.20,see "TREATMENT OVERVIEW",c25.A.15
- SRC.c25.C.15,See also Bone Marrow Transplantation,p12.c.1
- SRC.c25.C.18,see Biological Therapy,p08.c.1
- SRC.c25.C.21,see "TREATMENT OVERVIEW",c25.c.15
- SRC.c27.A.1,see "CANCER OF AN UNKNOWN PRIMARY SITE",c07.a.1
- SRC.c27.A.8,see "BRAIN TUMORS: ADULT",c05.a.1
- SRC.c27.C.1,see "CANCER OF AN UNKNOWN PRIMARY SITE",c07.c.1
- SRC.c27.C.8,see "BRAIN TUMORS: ADULT",c05.c.1
- SRC.c28.A.7,see "SUPPORTIVE CARE",c28.A.16
- SRC.c28.C.14,See Bone Marrow Transplantation,p12.c.1
- SRC.c28.C.7,see "SUPPORTIVE CARE",c28.c.17
- SRC.c29.A.10,see Diagram in Cervical Cancer,c09.a.4
- SRC.c29.A.12,see "TREATMENT FOLLOW-UP",c29.A.22
- SRC.c29.A.2,see Diagram in Cervical Cancer,c09.a.4
- SRC.c29.A.2,see "OVARIAN GERM CELL TUMORS",c30.a.1
- SRC.c29.C.11,see Diagram in Cervical Cancer,c09.c.4
- SRC.c29.C.2,see "OVARIAN GERM CELL TUMORS",c30.c.1
- SRC.c29.C.3,see Diagram in Cervical Cancer,c09.c.4
- SRC.c30.A.1,see Diagram in Cervical Cancer,c09.a.4
- SRC.c30.C.2,see Diagram in Cervical Cancer,c09.c.4
- SRC.c31.A.1,see "ISLET CELL AND OTHER PANCREATIC CARCINOMAS",c15.a.1
- SRC.p05.A.11,SEE "INTRAOPERATIVE RADIATION",p06.A.8
- SRC.p05.A.14,see Blood Transfusions & Cancer Treatment,p14.a.1
- SRC.p05.C.12,see Blood Transfusions & Cancer Treatment,p14.c.1
- SRC.p06.A.13,see Hyperthemic Perfusion Therapy,p11.a.1
- SRC.p06.A.17,see "Special Problems of Radiation Patients",p17.a.1
- SRC.p06.C.14,see Hyperthermic Perfusion Therapy,p11.c.1.
- SRC.p06.C.19,see "Special Nutritional Problems of Radiation Patients",p18.C.14
- SRC.p07.A.20,see Bone Marrow Transplantation,p12.a.1
- SRC.p07.A.23,see also What Happens in Biological Therapy,p08.a.1
- SRC.p07.A.24,see Coping with Treatment,p17.a.1
- SRC.p07.A.27,see Guarding Against Infection,p20.a.1
- SRC.p07.A.27,see Coping with Treatment,p17.a.1
- SRC.p07.A.27,Advances in Cancer Genetics,p36.a.1
- SRC.p07.A.9,see What Happens in Surgery,p05.a.9
- SRC.p07.C.20,See also Bone Marrow Transplantation,p12.c.1
- SRC.p07.C.23,See also What Happens in Biological Therapy,p08.c.1
- SRC.p07.C.24,see Coping with Treatment,p17.c.1
- SRC.p07.c.27,see Guarding Against Infection,p20.a.1
- SRC.p07.c.27,see Coping with Treatment,p17.a.1
- SRC.p07.c.27,see Investigational Anticancer Drugs,p35.a.1
- SRC.p07.C.9,see What Happens in Surgery,p05.c.9
- SRC.p11.A.3,See "MELANOMA",c25.a.1
- SRC.p11.C.3,See "MELANOMA",c25.c.1
- SRC.p13.C.13,see Coping with Treatment,p17.c.1
- SRC.p13.C.14,see How Cancer is Diagnosed,p02.c.1
- SRC.P15.C.11,see Palliative Care,p27.c.1
- SRC.p16.A.17,see Coping with Treatment,p17.a.1
- SRC.p16.A.19,See Deciding to Live,p28.a.1
- SRC.p16.C.19,See Deciding to Live,p28.c.1
- SRC.p16.A.19,See Survivorship,p31.a.1
- SRC.p16.C.17,see Wellness,p30.c.1
- SRC.p16.C.19,See Survivorship,p31.c.1
- SRC.p17.A.12,see Relaxation,p25.a.1
- SRC.p17.C.12,see Relaxation,p25.c.1
- SRC.p18.A.3,See Coping with Treatment,p17.a.1
- SRC.p18.C.3,See Coping with Treatment,p17.c.1
- SRC.p23.C.11,see the section "Hormonal Replacement Therapy in Women",p23.c.19
- SRC.p27.A.5,see Controlling Pain,p19.a.1
- SRC.p27.C.5,See Controlling Pain,p19.c.1
- SRC.p30.A.6,See Relaxation,p25.a.1
- SRC.p30.C.5,see Relaxation,p25.c.1
- SRC.p35.A.2,see also Deciding on the Appropriate Treatment,p04.a.1
- SRC.p35.A.13,see "MISCELLANEOUS DRUGS",p35.a.17
- SRC.p35.A.8,see "GROUP C DRUGS",p35.a.12
- SRC.p35.C.12,see "Miscellaneous Drugs",p35.c.15
- SRC.p35.C.2,see also Deciding on the Appropriate Treatment,p04.c.1
- SRC.p35.C.8,see "Group C Drugs",p35.c.12
- SRC.p36.A.4,see Understanding Cancer,p01.a.1
- SRC.p36.C.4,See Understanding Cancer,p01.c.1
- SRC.c06.A.15,shown on PAGE 29 to 42,c06.A.29
- SRC.c06.C.15,shown on PAGE 30 to 42,c06.C.30
- SRC.P06.A.19,see "HAIR LOSS",P17.A.38
- SRC.P06.C.20,see "HAIR LOSS",P17.C.37
- SRC.P26.C.8,Coping With Treatment Side Effects,P17.C.1
- SRC.P26.A.8,Coping With Treatment Side Effects,P17.A.1
- SRC.P26.C.12,Controlling Pain,P19.C.1
- SRC.P26.A.12,Controlling Pain,P19.A.1
- SRC.C44.A.14,See Stage Ib,C44.A.13
- SRC.C44.C.14,See Stage Ib,C44.C.13
- SRC.C44.C.15,See Stage Ib,C44.C.13
- SRC.C44.A.15,See Stage Ib,C44.A.13
- SRC.C44.A.18,See STAGE IIB,C44.A.15
- SRC.C44.C.18,See STAGE IIB,C44.C.15
- SRC.C44.A.19,See STAGE IB,C44.A.13
- SRC.C44.C.19,See STAGE IB,C44.C.13
- SRC.P24.A.19,Treatment Overview by Grade,C24.A.12
- SRC.P24.C.19,Treatment Overview by Grade,C24.C.12